Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies
- 1 September 1996
- journal article
- other
- Published by Elsevier in Contraception
- Vol. 54 (3) , 193-195
- https://doi.org/10.1016/s0010-7824(96)00166-7
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Oral contraceptives and thrombotic diseases: Impact of new epidemiological studiesContraception, 1996
- Third generation oral contraceptives and risk of myocardial infarction: an international case-control studyBMJ, 1996
- Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control studyBMJ, 1996
- Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic diseaseThe Lancet, 1995
- Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen componentsThe Lancet, 1995
- Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagenThe Lancet, 1995
- Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutationThe Lancet, 1994